EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ShK‐modified UCMSCs Inhibit M1‐Like Macrophage Polarization and Alleviate Osteoarthritis Progression via PI3K/Akt Axis

Wenshu Wu, Xueying An, Wang Gong, Lin Yang, Na Liu, Bin Liu, Baosheng Guo, Qing Jiang, Lan Li iD

Advanced Science · 2025-03 · 12 (9)

DOI: 10.1002/advs.202406822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.12.2024. Verfasst von Wenshu Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of M…. Hauptthemen laut MEDLINE: Osteoarthritis, Mesenchymal Stem Cells, Macrophages, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Major Research plan of NSFC, National Key Research and Development Project, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The potassium channel Kv1.3 plays an important role in regulating immune cell functions in many inflammatory diseases whereas rarely in osteoarthritis (OA). Here, it is demonstrated that the Kv1.3 of macrophages is upregulated in response to LPS stimulation, as well as in human OA synovium samples than non‐OA. Administration of Stichodactyla toxin (ShK), a Kv1.3 blocker, significantly inhibited cartilage degeneration and synovial inflammation in animal models of OA in vivo by inhibiting M1 macrophage polarization and reducing the production of inflammatory factors. In this study, a transgenically engineered human umbilical cord mesenchymal stem cell (UCMSC) delivery system is developed that secreted a peptide ShK, a Kv1.3 potassium blocker, into the knee articular cavity. Collectively, the results identified Kv1.3 as a potential therapeutic target for OA and demonstrated the efficacy of using ShK transgenic engineered UCMSCs as a delivery for the peptide in OA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisMesenchymal Stem CellsMacrophagesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktHumansAnimalsDisease ProgressionMiceUmbilical CordDisease Models, Animal

Stichwörter der Autor:innen

Kv1.3MacrophageOsteoarthritisUCMSC

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Division of Sports Medicine and Adult Reconstructive Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, 321 Zhongshan Road, Nanjing, Jiangs…
  • State Key Laboratory of Pharmaceutical Biotechnology Nanjing University, 22 Hankou Road, Nanjing, Jiangsu, 210093, P. R. China.
  • Branch of National Clinical Research Center for Orthopedics Sports Medicine and Rehabilitation, 321 Zhongshan Road, Nanjing, Jiangsu, 210008, P. R. China.
  • Institute of Medical 3D Printing, Nanjing University, Nanjing, 211166, P. R. China.
  • Jiangsu Engineering Research Center for 3D Bioprinting, 321 Zhongshan Road, Nanjing, 210000, P. R. China.
  • Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, 210008, P.R. China.

ORCID-Profile: Lan Li

Förderung

  • National Major Research plan of NSFC
  • National Key Research and Development Project
  • Natural Science Foundation of Jiangsu Province
  • Nanjing Health Technology Development Special Project
  • Jiangsu Province Medical Innovation Center of Orthopedic Surgery

Zitieren

APA

Wu, W., An, X., Gong, W., Yang, L., Liu, N., Liu, B., Guo, B., Jiang, Q., & Li, L. (2025). ShK‐modified UCMSCs Inhibit M1‐Like Macrophage Polarization and Alleviate Osteoarthritis Progression via PI3K/Akt Axis. Advanced Science, 12(9). https://doi.org/10.1002/advs.202406822

Vancouver

Wu W, An X, Gong W, Yang L, Liu N, Liu B, et al. ShK‐modified UCMSCs Inhibit M1‐Like Macrophage Polarization and Alleviate Osteoarthritis Progression via PI3K/Akt Axis. Advanced Science. 2025;12(9). doi:10.1002/advs.202406822

BibTeX
@article{Wu2025,
  author = {Wu, Wenshu and An, Xueying and Gong, Wang and Yang, Lin and Liu, Na and Liu, Bin and Guo, Baosheng and Jiang, Qing and Li, Lan},
  title = {ShK‐modified UCMSCs Inhibit M1‐Like Macrophage Polarization and Alleviate Osteoarthritis Progression via PI3K/Akt Axis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {9},
  doi = {10.1002/advs.202406822}
}
Kostenlos starten →